OptimizeRx (OPRX) Long-Term Investments (2022 - 2024)

OptimizeRx (OPRX) posted Long-Term Investments of $434000.0 for Q2 2024, down 13.37% sequentially from $501000.0 in Q1 2024.

OptimizeRx (OPRX) Long-Term Investments (2022 - 2024) Analysis & Trends

OptimizeRx has reported Long-Term Investments for 3 years, with the latest figure at $434000.0 in Q2 2024.

Quarterly Long-Term Investments changed N/A year-over-year to $434000.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $434000.0 (changed N/A YoY) and the FY2023 annual result came in at $568000.0, down 98.98% from the prior year.
Long-Term Investments retreated to $434000.0 in Q2 2024 per OPRX's latest filing, from $501000.0 in the prior quarter.
Over five years, Long-Term Investments peaked at $55.9 million in Q4 2022 and troughed at $434000.0 in Q2 2024.
A 3-year average of $11.6 million and a median of $568000.0 in 2023 frame the typical range for Long-Term Investments.
The widest YoY moves for Long-Term Investments: up 98.98% in 2023, down 98.98% in 2023.
Over 3 years, Long-Term Investments stood at $55.9 million in 2022, then plunged by 98.98% to $568000.0 in 2023, then fell by 23.59% to $434000.0 in 2024.
According to Business Quant data, Long-Term Investments over the past three periods registered $434000.0, $501000.0, and $568000.0 for Q2 2024, Q1 2024, and Q4 2023 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Investments (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn	-
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn	7.54 Mn
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn	-
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn	-
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn	84.74 Mn
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn	-
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn	-
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn	-
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn	84.29 Mn
10	OptimizeRx	164.25 Mn	140.15 Mn	15.69 Mn	-

Download Data